Zobrazeno 1 - 10
of 99
pro vyhledávání: '"semaxanib"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current Topics in Medicinal Chemistry. 20:1461-1467
Aims: To explore more active fluoroquinolone anticancer candidates. Background: Cancer which can affect almost any part of the body, is most striking and deadliest disease. It is estimated that around one in five people globally develop cancer during
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:129-133
Analysis of the crystal structure of tyrosine kinase in complexation with an ATP analogue, supplemented with the molecular docking studies of semaxanib and sunitinib in the ATP binding site of the enzyme enabled us to make design of a series of tyros
Autor:
Shireen Usman, Sreeya Yalamanchali, Dan E. Bruegger, Joel W Jones, Larry A. Hoover, Sufi M. Thomas, Tran B. Le, Ossama Tawfik, Jacob New
Publikováno v:
International Forum of Allergy & Rhinology. 7:973-979
Background Juvenile nasopharyngeal angiofibroma (JNA) is a benign tumor that presents in adolescent males. Although surgical excision is the mainstay of treatment, recurrences complicate treatment. There is a need to develop less invasive approaches
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:1602-1607
In an effort to optimize the structural requirements for combined cytostatic and cytotoxic effects in single agents, a series of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines 3-7 were synthesized and evaluated as inhibitors of receptor tyrosine
Publikováno v:
Oncotarget
// Edmond F. O’Donnell 1, 2 , Hyo Sang Jang 1, 2 , Martin Pearce 1, 2 , Nancy I. Kerkvliet 2 , Siva Kumar Kolluri 1, 2 1 Cancer Research Laboratory, Oregon State University, Corvallis, Oregon, USA 2 Department of Environmental and Molecular Toxicol
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 120, Iss, Pp-(2019)
Strategies targeting endoglin are currently being investigated in clinical trials as an anti-angiogenic therapy. The redundancy between endoglin and vascular endothelial growth factor (VEGF) signaling in angiogenesis was verified. Increased endoglin
Publikováno v:
Toxicology in Vitro. 71:105063
Vascular endothelial growth factor (VEGF) promotes tumor angiogenesis through stimulating the proliferation and survival of endothelial cells. The severe adverse events caused by VEGF inhibitors might include immune-related ones; however, details of
Publikováno v:
European Journal of Medicinal Chemistry. 200:112359
Cancer chemotherapy is frequently hampered by drug resistance, so the resistance to anticancer agents represents one of the major obstacles for the effective cancer treatment. Indole derivatives have the potential to act on diverse targets in cancer
Publikováno v:
Archiv der Pharmazie. 353:1900367
The isatin framework is a useful template for the development of novel anticancer agents. This is exemplified by the fact that several isatin-based anticancer agents, such as semaxanib, sunitinib, nintedanib, and hesperadin, are already in use or und